Europe Home Respiratory Care Services Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Home respiratory care services in Europe cover the delivery of oxygen therapy, non-invasive ventilation, nebulization treatments, and continuous positive airway pressure therapy to patients in residential settings. The market spans equipment provision, clinical monitoring, supply chain management, and nursing support delivered by specialized home healthcare providers and device manufacturers. Reimbursement frameworks across EU member states, particularly in Germany, France, the United Kingdom, and Italy, have progressively expanded coverage for home-based respiratory therapies, supporting broader adoption.

• •Market valued at $3.5 billion in 2025 with a projected 8.5% annual growth rate through the early 2030s
• •Primary services include home oxygen therapy, non-invasive ventilation, sleep apnea management, and nebulized drug delivery
• •Growth supported by EU healthcare policies promoting hospital-at-home and integrated care models

The rising prevalence of chronic obstructive pulmonary disease and obstructive sleep apnea across Europe's aging population is a primary catalyst, with both conditions requiring long-term management well-suited to home-based delivery. The COVID-19 pandemic accelerated infrastructure investments in remote patient monitoring and home oxygen services, creating lasting capacity. Additionally, national health systems face persistent pressure to reduce hospital admissions and associated costs, making home respiratory care an economically attractive alternative.

• •COPD affects over 30 million people across Europe, driving sustained demand for long-term oxygen therapy
• •Post-pandemic normalization of telehealth and remote monitoring has lowered barriers to home-based respiratory care adoption
• •Hospital-at-home initiatives and bundled payment models incentivize shifting respiratory care from inpatient to home settings

Oxygen therapy constitutes the largest segment, encompassing stationary concentrators, portable oxygen systems, and liquid oxygen supply, while non-invasive ventilation and positive airway pressure devices serve the fast-growing sleep apnea population. Geographically, Germany and the United Kingdom lead the market due to large patient populations and established home healthcare infrastructures, followed by France and Italy. Eastern European markets are expanding more rapidly from a smaller base as healthcare modernization proceeds and reimbursement access improves.

• •Oxygen therapy dominates the market, with sleep apnea-related devices representing the fastest-growing subcategory
• •Germany, the UK, and France together account for the majority of market share within Western Europe
• •Eastern Europe is experiencing above-average growth driven by healthcare infrastructure development and rising disease awareness

What are the recent trends and outlook?

Digital health integration is reshaping the market through connected nebulizers, smart inhalers with adherence tracking, and remote patient monitoring platforms that transmit physiological data to clinicians in real time. Portable and lightweight device designs are expanding the addressable patient population by enabling greater mobility and quality of life. Looking ahead, artificial-driven care coordination, predictive analytics for exacerbation detection, and value-based care contracts are expected to further institutionalize home respiratory care as a standard of practice across European health systems.

• •Smart inhalers and connected respiratory devices with app-based adherence tracking are gaining clinical and payer acceptance
• •Battery-powered portable oxygen concentrators and compact NIV devices are broadening eligibility for home-based care
• •Partnerships between device manufacturers, software platforms, and care providers are creating integrated home respiratory care ecosystems